Status:

COMPLETED

A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women.

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions:

Drug Interactions

Contraception

Eligibility:

FEMALE

18-45 years

Phase:

PHASE1

Brief Summary

The purpose of the study is to assess the effect of folic acid administration on the blood level and the breakdown products of oral contraceptive (OC) \[250 mcg NGM/35 mcg EE\] tablets.

Detailed Description

This is an open-label, randomized (study drug assigned by chance), single-center, pharmacokinetic interaction study. Healthy adult women who met the prestudy eligibility criteria were randomized to 1 ...

Eligibility Criteria

Inclusion

  • Healthy
  • Nonpregnant
  • Nonlactating
  • Nonsmoking women
  • Weighing at least 110 pounds
  • With regular menstrual cycles
  • A body mass index between 16 and 29.9 kg/m2
  • And a hematocrit of at least 36%

Exclusion

  • History or presence of disorders commonly accepted as contraindications to sex hormonal therapy including: thromboembolic disorders cerebral vascular or coronary artery disease, chronic untreated hypertension, or migraines, benign or malignant liver tumor that developed during the use of OC
  • Known or suspected estrogen-dependent neoplasia
  • Presence of disorders commonly accepted as contraindications to combined OC including: undiagnosed abnormal vaginal bleeding, any neurovascular lesion of the eye or serious visual disturbance, or liver disease
  • Intake any multivitamin or folic acid-containing supplements within 30 days before study admission
  • Used a steroid hormone-containing intrauterine device within 3 months prior to study admission
  • Used any medications that were known cytochrome P-450 enzyme inducers or inhibitors (e.g., St. John's Wort, cimetidine or rifampin), within 60 days before dosing.

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2005

Estimated Enrollment :

47 Patients enrolled

Trial Details

Trial ID

NCT00709332

Start Date

January 1 2005

End Date

February 1 2005

Last Update

June 8 2011

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.